108 related articles for article (PubMed ID: 2286607)
1. The effect of thromboxane synthetase inhibition on cardiopulmonary function during endotoxemia in sheep.
Fujioka K; Sugi K; Traber LD; Herndon DN; Traber DL
J Burn Care Rehabil; 1990; 11(6):531-7. PubMed ID: 2286607
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane synthase inhibition and cardiopulmonary function during endotoxemia in sheep.
Fujioka K; Sugi K; Isago T; Flynn JT; Traber LD; Herndon DN; Traber DL
J Appl Physiol (1985); 1991 Oct; 71(4):1376-81. PubMed ID: 1757360
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thromboxane synthesis reduces endotoxin-induced right ventricular failure in sheep.
Redl G; Abdi S; Traber LD; Nichols RJ; Flynn JT; Herndon DN; Traber DL
Crit Care Med; 1991 Oct; 19(10):1294-302. PubMed ID: 1914487
[TBL] [Abstract][Full Text] [Related]
4. [Right heart function and endotoxemia in animals].
Redl G
Wien Klin Wochenschr Suppl; 1991; 188():1-20. PubMed ID: 1833887
[TBL] [Abstract][Full Text] [Related]
5. Effect of a thromboxane synthetase inhibitor on protamine-induced circulatory changes in sheep.
Sugi K; Esato K
Surgery; 1993 Sep; 114(3):586-90. PubMed ID: 8367815
[TBL] [Abstract][Full Text] [Related]
6. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
Kubo K; Kobayashi T
Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941
[TBL] [Abstract][Full Text] [Related]
7. Selective thromboxane A2 synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injury.
Westphal M; Noshima S; Isago T; Fujioka K; Maybauer MO; Maybauer DM; Traber LD; Flynn JT; Westphal-Varghese BB; Traber DL
Anesthesiology; 2005 May; 102(5):954-61. PubMed ID: 15851882
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of immunoreactive atrial natriuretic factor release in an ovine model of endotoxemia.
Redl G; Woodson L; Traber LD; Rogers CS; Abdi S; Flynn JT; Herndon DN; Traber DL
Circ Shock; 1992 Sep; 38(1):34-41. PubMed ID: 1394862
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vascular response to thrombin: effects of thromboxane synthetase inhibition with OKY-046 and OKY-1581.
Garcia-Szabo R; Kern DF; Malik AB
Prostaglandins; 1984 Dec; 28(6):851-66. PubMed ID: 6543018
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane synthetase inhibition and thromboxane receptor blockade preserve pulmonary and circulatory function in a porcine burn sepsis model.
Iglesias G; Zeigler ST; Lentz CW; Traber DL; Herndon DN
J Am Coll Surg; 1994 Aug; 179(2):187-92. PubMed ID: 8044389
[TBL] [Abstract][Full Text] [Related]
11. Effect of OKY 046, a thromboxane synthase inhibitor, on lung vascular permeability after pulmonary embolism in sheep.
Lelcuk S; Klausner JM; Merhav A; Rozin RR
Thorax; 1987 Sep; 42(9):676-80. PubMed ID: 3686459
[TBL] [Abstract][Full Text] [Related]
12. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
Davenport NJ; Goldstein RE; Feuerstein GZ
J Cardiovasc Pharmacol; 1991 Apr; 17(4):641-6. PubMed ID: 1711633
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effects of a pyridoquinazoline thromboxane synthetase inhibitor on arachidonic acid metabolites and hemodynamics during E. coli endotoxemia in anesthetized sheep.
Morel DR; Huttemeier PC; Skoskiewicz MJ; Nguyenduy T; Melvin C; Robinson DR; Zapol WM
Prostaglandins; 1987 Jun; 33(6):879-902. PubMed ID: 3118413
[TBL] [Abstract][Full Text] [Related]
14. Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia.
Li JX; Oliver JR; Lu CY; Philips JB
Am J Med Sci; 1995 Sep; 310(3):103-10. PubMed ID: 7668305
[TBL] [Abstract][Full Text] [Related]
15. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
16. Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep.
Koizumi T; Kubo K; Kobayashi T; Sekiguchi M
J Appl Physiol (1985); 1992 Aug; 73(2):618-24. PubMed ID: 1399989
[TBL] [Abstract][Full Text] [Related]
17. Cardiac dysfunction after acute endotoxin administration in conscious sheep.
Sugi K; Newald J; Traber LD; Maguire JP; Herndon DN; Schlag G; Traber DL
Am J Physiol; 1991 May; 260(5 Pt 2):H1474-81. PubMed ID: 2035670
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary changes with intermittent endotoxin administration in sheep.
Godsoe A; Kimura R; Herndon D; Flynn JT; Schlag G; Traber L; Traber D
Circ Shock; 1988 Jun; 25(2):61-74. PubMed ID: 3292076
[TBL] [Abstract][Full Text] [Related]
19. Effects of thromboxane synthetase inhibition on postburn mesenteric vascular resistance and the rate of bacterial translocation in a chronic porcine model.
Tokyay R; Loick HM; Traber DL; Heggers JP; Herndon DN
Surg Gynecol Obstet; 1992 Feb; 174(2):125-32. PubMed ID: 1734570
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion.
Austin JC; Berrizbeitia LD; Schoen FJ; Kauffman RP; Hechtman HB; Cohn LH
Am Heart J; 1988 Mar; 115(3):505-9. PubMed ID: 3344655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
